Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors

There are no relevant meta-analyses that have assessed the safety of the sodium-glucose transporter 2 (SGLT2) inhibitors in different chronic diseases. We aimed at evaluating the safety of four SGLT2 inhibitors in three chronic diseases by meta-analysis of the large randomized trials of SGLT2 inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Mei, Ding, Liang-Liang, Zhang, Miao, Zhou, Hai-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481734/
https://www.ncbi.nlm.nih.gov/pubmed/33887983
http://dx.doi.org/10.1177/14791641211011016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481734/
https://www.ncbi.nlm.nih.gov/pubmed/33887983
http://dx.doi.org/10.1177/14791641211011016

Ejemplares similares